Panretinal Photocoagulation Combined With Intravitreal Bevacizumab in High-Risk Proliferative Diabetic Retinopathy

Intravitreal bevacizumab before PRP can be an effective adjunctive treatment to PRP in the treatment of high-risk proliferative diabetic retinopathy, especially if there is not CSME.